NanoViricides
NNVC
#10671
Rank
A$39.5 M
Marketcap
A$1.55
Share price
5.07%
Change (1 day)
-28.61%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): A-$0.67

According to NanoViricides's latest financial reports the company's current EPS (TTM) is A-$0.62. In 2025 the company made an earnings per share (EPS) of A-$0.88 an increase over its 2024 EPS that were of A-$0.98.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.67-24.21%
2025A-$0.88-10%
2024A-$0.98-5.41%
2023A-$1.045.71%
2022A-$0.98-13.58%
2021A-$1.14-66.11%
2020A-$3.351.7%
2019A-$3.30-10.98%
2018A-$3.70-22.35%
2017A-$4.77-10.53%
2016A-$5.33375%
2015A-$1.12-85.19%
2014A-$7.5842.11%
2013A-$5.3326.67%
2012A-$4.21-6.25%
2011A-$4.4914.28%
2010A-$3.93100%
2009A-$1.96-0%
2008A-$1.96-33.33%
2007A-$2.95-0%
2006A-$2.954445.07%
2005A-$0.06481

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
A$10.41-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.01-912.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.99-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.45-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A-$0.76 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A-$2.43 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA